Background. Although smoking cessation is desirable from a public health perspective, its consequences
Smoking related diseases cost the British National or not smokers impose a net financial burden ought to be of very limited importance" (page 1057). A more Health Service (NHS) somewhere between £1.4 billion and £1.7 billion every year. 1 It is hardly surprising, appropriate health policy objective is to increase life years and improve health related quality of life. What therefore, that reductions in these health care costs should be highlighted as a major benefit of smoking matters, therefore, is how the cost of achieving these health gains through smoking cessation interventions cessation. However, non-smokers live longer than smokers. In the USA 78% of male non-smokers are still compares with the cost of achieving them by other means. alive at the age of 70 compared with 57% of smokers. At the age of 80 the figures are 50% and 21%, respectively. 2 It was not the intention of the Barendregt study, nor is it the intention of the present review, to address that Non-smokers thus impose a greater burden on health care resources in old age than their shorter lived fellow question. Reviews of the cost effectiveness of smoking cessation are available elsewhere. 3 4 Here, the focus is citizens who smoke. This has led to much recent research into who has the greater lifetime health care costs, the on the cost to society of smoking cessation. We shall address this by critically examining the approach and smoker or the non-smoker? In the introductory article Barendregt and colleagues conclude that, despite the assumptions of the Barendregt study with respect to health care costs of smoking, and by considering the short term savings to society from smokers quitting, the long term effect will be a net increase in health care wider economic implications of changing smoking habits, since the financial costs of smoking are not confined costs. 2 The public health policy implications of this conto health service resource use. clusion require several additional issues to be addressed, including the key question-so what? Barendregt and colleagues quite rightly point out that the primary obDoes the introductory article underestimate the health care costs of smoking? jective of health policy is not to save money, and therefore evaluation of policy measures cannot be on the The estimate which Barendregt and colleagues provide for the lifetime health care costs of smokers and nonbasis of whether or not they produce net resource savings: ". . . in formulating public health policy, whether smokers is based on the incidence, prevalence, and mortality associated with five major categories of smokreport estimated this risk enhancement to be even higher at 53% for Russian women whose husbands smoke. 13 ing related diseases, and the relevant "rate ratios" (differences in frequency of disease between smokers Similarly, a 23% increased risk of ischaemic heart disease has been shown for lifelong non-smokers who live with and non-smokers) derived from the literature. These five major categories comprised: heart disease, stroke, smokers rather than non-smokers. 14 Passive smoking is also associated with a 25% increase in the risk of acute lung cancer, a heterogeneous group of other cancers, and chronic obstructive pulmonary disease. respiratory illness. 15 Children whose parents smoke have an increased risk This approach is a wholly appropriate one which will capture the bulk of the extra health care costs of smoking.
of a wide range of respiratory illnesses. [16] [17] [18] [19] [20] In the USA an EPA report 21 estimated that the respiratory health of There are, however, several reasons why such an approach will understate the true extra costs of smoking.
between 200 000 and one million asthmatic children is worsened by exposure to environmental tobacco smoke. These we shall discuss further.
An excess of hospital attendances (which were attributed to environmental tobacco smoke) suggested that children of smoking mothers had incurred health ex-        penditures for respiratory illness at a rate more than two and a half times that of children of non-smoking While accepting that the five categories of disease used in the Barendregt study represent the bulk of smoking mothers. 22 It could be, however, that socioeconomic factors associated with smoking had also played a role. related morbidity and mortality, and hence the majority of health care costs, the list of other diseases in which
The direct annual medical expenditure for early childhood respiratory illness attributable to maternal smoking smoking has been implicated is long and growing. Omission of these other smoking induced diseases thus untotalled $661 million for all children under the age of six. In Hong Kong the cost per child of general practice derstates the true health care costs of smoking. For example, there is mounting evidence of a relationship consultations for cough, phlegm or wheeze was 14% higher for children living in a one smoker home, and between smoking and the incidence of cataract, with a relative risk for smokers of more than 20 cigarettes per 25% for two or more smokers, compared with no smokers in the home. 23 day as high as 2.16. 5 6 Given that over 1.1 million cataract operations were performed in the USA in 1989 and that reimbursement for these procedures accounts for approximately 12% of the Medicare budget, 7 the            extent of the extra health care costs in this area is clearly considerable.
In a series of meta-analyses DiFranza and Lew 24 estimated that each year in the USA smoking during Evidence of an increased risk of hip fractures in smokers has also been reported. 8 A recent meta-analysis 9 pregnancy is responsible for 19 000-141 000 abortions, 32 000-61 000 low birth weight babies, 14 000-26 000 suggests that bone density diminishes after the age of 50 leading to an increased risk of hip fracture for current admissions to neonatal intensive care units (NICU), 1900-4800 deaths from perinatal disorders, and 1200-smokers of 17% at age 60, 41% at age 70, and 108% at age 90. Again, given the high volume of hip fracture 2200 deaths from sudden infant death syndrome. The wide ranges are due to the uncertainty about the prooperations this translates into considerably increased health care costs.
portion of women who smoke whilst pregnant and the fact that many estimates have not been adjusted to take account of confounding factors. Costs of NICU cases are particularly high, and recent        -   US figures suggest that smoking is responsible for 15% of all preterm births and 20-30% of all infants with low There is evidence that smoking inhibits recovery from a number of non-smoking related conditions. It has birth weight that require NICU admission. 25 Li et al 26 have estimated the average cost per NICU admission been shown to be a risk factor for increasing the time patients spend in a post-anaesthesia care unit (PACU) at between $5213 and $10 306, but argued that this may overstate the cost attributable to smoking as the following a wide range of surgical procedures. 10 Thirty eight percent of non-smokers were discharged from the impact of smoking on birthweight is greater in the 1500-2500 g category than below 1500 g where costs PACU less than one hour after admission compared with only 23% of smokers. Similar problems have been are higher. Their adjusted net incremental cost per low birthweight baby due to smoking ranged from $4256-reported for delayed wound healing. 11 They have been explained by nicotine, carbon monoxide, and hydrogen 8640. The extra health care costs of babies who survive but have long term health care needs due to their cyanide undermining expeditious wound repair.
initial low birthweight would have to be added to this. Whichever estimates are used, it is apparent that the costs calculated by Barendregt and colleagues omit       The Barendregt study assumed that smoking induced major health care costs attributable to smoking. disease is confined to smokers. This ignores mounting evidence of the health effects of passive smoking on non-smokers. In the USA the Environment Protection            Agency (EPA) attributed 53 000 deaths of non-smokers each year to passive smoking. 12 There is an implicit assumption in the Barendregt dynamic model that the higher morbidity and mortality The increased risks of lung cancer and ischaemic heart disease from passive smoking have both been among smokers is due entirely to their smoking. There is considerable evidence that demographic and besubject to recent meta-analyses. From 37 identified studies it was estimated that living with someone who havioural differences between smokers and non-smokers might partly explain health related differences between smokes increases the risk of lung cancer by 26%, after adjustment for bias and dietary factors. 9 A subsequent the two groups. For example, smokers tend to be of 27 have a lower level of per year. 39 In addition to the health care costs of treating burn victims, property damage from fires caused by education, 28 take less exercise, 29 eat a less healthy diet, 30 and consume more alcohol 28 31 than non-smokers. cigarettes has been valued at $552 million per year. All of these are associated with higher morbidity and mortality and, taken together, suggest that a population of smokers who quit would continue to have higher Beneficial economic effects of smoking Any assessment of the economic costs of smoking, and health care costs than a population of non-smokers, even in the long term. In this respect, then, the inthe potential economic benefits of cessation, would be incomplete unless it also took account of the positive troductory article may have overestimated the true health care cost of smoking.
economic effects of smoking and the consequences on these of smoking cessation. Smoking has also been reported to have beneficial effects on a wide range of medical conditions; the evidence has been reviewed by Other (non-health care) costs of smoking Baron. 40 Here we focus solely on the potential benefits While the question addressed in the Barendregt study to the economy. was limited to differences in lifetime health care costs between smokers and non-smokers, there are other costs (and benefits) which smoking imposes on the economy.
     There is no reason in principle why these costs should Although strictly tobacco duty is a transfer payment be regarded as any less relevant to society than health rather than a true economic cost, 41 it is a major source care costs.
of government revenue and any reduction in smoking would involve a significant loss to the Exchequer. In 1994, 460 million cigarettes were consumed in the UK        representing a spending of £10 017 million. Of this the Smoking is a major cause of sickness absence which government received duty of £8463 million (80% of imposes major costs on industry from lost productivity. retail price). This represents about 10% of total Customs In the UK approximately 50 million working days are and Excise revenue and 3% of total government direct lost each year due to smoking, 32 valued at £1710 million. and indirect tax revenue. 42 Revenue from tobacco duty This is more than the estimated cost of smoking to the is considerably higher than the costs smoking imposes NHS. 1 on society. US smokers are absent from work approximately 6.5 days more per year than non-smokers. 33 Costs of lost productivity of persons disabled by smoking related       diseases and forfeited earnings of those dying pre- maturely of such diseases have been put at $47 billion Employment in the UK in the tobacco industry has per year. 34 To this should be added another $8.6 billion been falling over recent decades. 42 The economic conof lost productivity due to passive smoking. 35 sequences of a further loss of jobs is commonly brought The processes which give rise to absence from the to society's attention by the tobacco industry, and there workplace, however, are complex. The simple obare many other jobs which depend indirectly on smokservation of higher rates of absence among smokers may ing, including the retail and wholesale trade sectors. therefore be insufficient to establish a causal connection While reductions in smoking prevalence will reduce between smoking and absence from work. 36 In a recent jobs in the tobacco industry, this will not necessarily study Bush and Wooden 37 showed that morbidity alone lead to an overall increase in unemployment. Much of cannot fully explain the higher sickness absence of the money which smokers currently spend on cigarettes smokers, and speculated that some behavioural charwill be spent elsewhere, increasing the demand for other acteristics associated with smokers may be partly regoods and services and affecting employment in these sponsible. Nevertheless, even after controlling for other industries. The extent of this effect depends on numerous health indicators (alcohol, exercise, weight), the spending patterns of former smokers. McNicoll and job characteristics (employment status, hours worked, Boyle 43 estimated that a complete cessation of cigarette income, occupation), and demographic characteristics purchasing by the citizens of Glasgow would bring (age, sex, ethnicity, marital status, education, place of net benefits to the Scottish economy. Each £1 million residence), the study still showed smoking status to be reduction in cigarette expenditure would lead to a net highly correlated with absence from work.
increase in Scottish output of £1.1 million and a net Although it would be wrong to suggest that the whole increase in Scottish employment of 64 jobs. cost of the higher absenteeism of smokers is due to their A similar result was found by Buck et al 42 who essmoking induced morbidity, the further cost to society timated the effect of a 40% reduction in smoking-the from smoking is both real and important. Even if lifetime target set by the 1992 UK policy document "The Health health care costs are greater for non-smokers than of the Nation". 44 Using a reasonable set of assumptions smokers (as Barendregt and colleagues suggest), the they estimated that the reduction in spending on tobacco difference is more than offset by the gain in lifetime would result in a net overall increase of 150 000 jobs in work productivity. This suggests that the economic the UK. benefit of smoking cessation will be positive (and large) Even in tobacco growing countries the consequent regardless of the net effect on health care costs.
gain in jobs in other industries may exceed the loss experienced in the tobacco industry as tobacco consumption diminishes. In the USA Warner et al 45 compared the south-east tobacco growing region with eight     In the UK fires caused by cigarette smoking have been non-tobacco regions and estimated that, with no spending on tobacco, the south-east would lose 222 000 jobs estimated to cost £20 million per annum. 38 In the USA such fires are the leading cause of civilian fire deaths but this would be compensated by a gain of 355 000 jobs throughout the rest of the country (assuming gov-(2300 deaths per year) with an additional 5000 injuries group.bmj.com on April 9, 2017 -Published by http://thorax.bmj.com/ Downloaded from LEARNING POINTS * Smokers impose costs on society for health services from smoking related diseases. * Non-smokers live longer and thus impose higher costs on society in old age. * Whether or not the short term health care cost savings from smoking cessation outweigh the long term extra costs of a larger elderly population depends on the chosen "discount rate". * The cost of smoking to society includes much more than health care costs, and the cost of lost productivity at work from smoking related sickness absence is greater than the health care cost of smoking related illness. * While cost saving is a benefit, the principal benefit of smoking cessation is the health gain associated with a longer living, healthier population. * From a policy perspective, what matters is how cost effective are smoking cessation interventions compared with other preventive and curative interventions.
ernment replaces lost revenue by increasing income count rate is applied. The health care costs of nonsmokers living longer are further in the future than the tax).
smoking related health care costs of smokers. Quitting therefore produces early cost savings and late cost increases. In the Barendregt analysis the "break even"   Shorter life expectancy also means reduced expenditure point occurs 26 years after the population of smokers quits if a zero discount rate is applied. At a rate of 3% on pensions. As with tobacco duty, pensions are transfer payments rather than true costs 41 but do nevertheless the break even time rises to 31 years, at 5% it rises to 37 years, and at 10% it is not reached by 50 years, and represent significant losses to the Exchequer. Manning et al 46 have estimated that every pack of cigarettes may never be reached at all. Their response to this is to argue that "discounting smoked decreases life expectancy by 137 minutes and pension costs by $1.82.
. . . should not be applied in a descriptive context, such as the estimation of life-time costs" (page 1056). This view is untenable and presenting cost saving data in nominal (undiscounted) figures is highly misleading.
Effects of the passage of time
Assessing the costs to society of smoking-and hence
Smoking affects the claims on health care resources such as doctor time, medication, and hospital beds. The the benefits to society of non-smoking-is complicated by the time dimension in several ways. Firstly, as Bamonetary value of these resources cannot be expressed independently of time unless supported by an argument rendregt and colleagues point out, there will be a considerable time lag between smoking cessation and the of social indifference-which is indefensible on theoretical grounds and inconsistent with observed behaviour. consequent beneficial effects on morbidity and mortality. The current health care costs of non-smokers A final complicating feature of the passage of time relates to the rate at which smoking cessation can realcannot therefore be used as an estimate of what would happen if existing smokers quit. They deal with this by istically be expected to occur. While total population abstinence may be an ultimate policy goal, it is inusing a dynamic model based on a series of linked life tables for different points in time where population size, conceivable that all smokers would quit simultaneously. The effects on all the above economic costs depend disease incidence, and associated mortality in any period are determined by the relevant values for the previous critically on the rate at which smokers cease to smoke. period.
Secondly, a basic economic principle is that society is not indifferent about the timing of costs and benefit, Conclusions The methodology of the Barendregt study was espreferring benefits sooner and costs later. 41 Economists thus adjust future costs and benefits to "present values" sentially sound. It accounted for all the main sources of smoking related health care costs but it was not by applying an appropriate "discount factor". While there is universal agreement among economists of the fully comprehensive. The authors' conclusion that the lifetime costs for non-smokers are higher than those for need to discount future monetary costs and benefits (the issue of discounting intangible benefits such as smokers depended on their use of low (or zero) discount rates. Rates above 4.5% (cf UK Treasury discount rate life years remains controversial 47 ), there is no similar agreement on the appropriate rate to use. In the UK of 6%) produce the opposite result. Furthermore, the costs to society of smoking are considerably wider than the Treasury currently specifies a discount rate of 6% for public sector evaluations for consistency.
those of health care addressed by the Barendregt study. This consequently underestimated the potential benefits Barendregt and colleagues point out that "having all smokers quit becomes economically attractive when the of total smoking cessation. From a policy perspective, however, none of this really future benefits are larger than the future costs. . ." (page1056) but this will depend crucially on what dismatters much. What does matter is what can be done
